By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Adamas Pharmaceuticals 

1900 Powell Street
Suite 1050
Emeryville  California  94608  U.S.A.
Phone: 510-450-3500 Fax: 510-428-0519


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Adamas Pharmaceuticals (ADMS) Issued Six Additional U.S. Patents 12/4/2014 4:31:36 PM
Adamas Pharmaceuticals (ADMS) To Present At Piper Jaffray Healthcare Conference 11/19/2014 12:45:19 PM
Adamas Pharmaceuticals (ADMS) To Present At 2014 Credit Suisse Healthcare Conference 11/6/2014 8:21:18 AM
Adamas Pharmaceuticals (ADMS) Reports Third Quarter 2014 Financial Results 11/5/2014 7:46:03 AM
Adamas Pharmaceuticals (ADMS) Expands Its Phase 3 Program With ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Patients With Parkinson's Disease 10/29/2014 7:19:28 AM
Adamas Pharmaceuticals (ADMS) Reports Second Quarter 2014 Financial Results 8/8/2014 10:50:57 AM
United States Patent Issued To Adamas Pharmaceuticals (ADMS) 8/5/2014 3:49:07 PM
Adamas Pharmaceuticals (ADMS) To Present At JMP Securities Healthcare Conference 2014 6/17/2014 12:25:21 PM
Adamas Pharmaceuticals (ADMS) Announces Rater Training Data On ADS-5102 For Parkinson's Disease Patients With Levodopa-Induced Dyskinesia 6/10/2014 10:08:44 AM
Adamas Pharmaceuticals (ADMS) Initiates Phase 3 Trial For ADS-5102 In Parkinson's Disease Patients With Levodopa-Induced Dyskinesia 6/10/2014 9:03:15 AM
1234
//-->